NCIt definition : A preparation of autologous central memory-enriched T-cells (Tcm) that have been transduced
with a self-inactivating (SIN) lentiviral vector expressing a hinge-optimized chimeric
antigen receptor (CAR) comprised of a CS1 (CD2 subset 1; SLAM family member 7; SLAMF7;
CD319; CRACC)-specific single chain variable fragment (scFV), fused to the costimulatory
signaling domain of 4-1BB (CD137), and a truncated human epidermal growth factor receptor
(huEGFRt), with potential antineoplastic activity. Upon intravenous infusion, anti-CS1-CAR-4-1BB-CD3z-EGFRt-expressing
Tcm-enriched T-lymphocytes target and induce selective toxicity in CS-1-expressing
tumor cells. Devoid of both ligand binding domains and tyrosine kinase activity, the
expressed huEGFRt facilitates both in vivo detection of the administered, transduced
T-cells and can promote elimination of those cells through a cetuximab-induced antibody-dependent
cellular cytotoxicity (ADCC) response. CS1, a cell surface glycoprotein of the signaling
lymphocyte activation molecule (SLAM) receptor family, is highly expressed on certain
malignant plasma cells.;